|
Originally published In Press as doi:10.1074/jbc.M003634200 on August 4, 2000
J. Biol. Chem., Vol. 275, Issue 42, 32901-32905, October 20, 2000
Identification of a Novel Inhibitor Specific to the Fungal
Chitin Synthase
INHIBITION OF CHITIN SYNTHASE 1 ARRESTS THE CELL GROWTH, BUT
INHIBITION OF CHITIN SYNTHASE 1 AND 2 IS LETHAL IN THE PATHOGENIC
FUNGUS CANDIDA ALBICANS*
Masayuki
Sudoh ,
Toshikazu
Yamazaki ,
Kazunao
Masubuchi§,
Mikio
Taniguchi§,
Nobuo
Shimma§,
Mikio
Arisawa , and
Hisafumi
Yamada-Okabe ¶
From the Department of Mycology and Oncology and the
§ Department of Chemistry, Nippon Roche Research Center,
Kanagawa 247-8530, Japan
Received for publication, April 28, 2000, and in revised form, July 31, 2000
 |
ABSTRACT |
As in Saccharomyces cerevisiae, the
pathogenic fungus Candida albicans harbors three chitin
synthases called CaChs1p, CaChs2p, and CaChs3p, which are structurally
and functionally analogous to the S. cerevisiae ScChs2p,
ScChs1p, and ScChs3p, respectively. In S. cerevisiae,
ScCHS1, ScCHS2, and ScCHS3 are all
non-essential genes; only the simultaneous disruption of
ScCHS2 and ScCHS3 is lethal. The fact that a
null mutation of the CaCHS1 is impossible, however, implies
that CaCHS1 is required for the viability of C. albicans. To gain more insight into the physiological importance of CaCHS1, we identified and characterized a novel
inhibitor that was highly specific to CaChs1p. RO-09-3143 inhibited
CaChs1p with a Ki value of 0.55 nM in a
manner that was non-competitive to the substrate
UDP-N-acetylglucosamine. RO-09-3143 also hampered the
growth of the C. albicans cells with an MIC50
value of 0.27 µM. In the presence of RO-09-3143, the
C. albicans cells failed to form septa and displayed an
aberrant morphology, confirming the involvement of the C. albicans Chs1p in septum formation. Although the effect of
RO-09-3143 on the wild-type C. albicans was fungistatic, it
caused cell death in the cachs2 null mutants but not in
the cachs3 null mutants. Thus, it appears that in C. albicans, inhibition of CaChs1p causes cell growth
arrest, but simultaneous inhibition of CaChs1p and CaChs2p is lethal.
 |
INTRODUCTION |
Candida albicans is an opportunistic pathogen and is
one of the most common pathogens in humans. In healthy individuals, it remains in the oral cavity, gastrointestinal tract, and genitalia; however, it colonizes and invades various tissues and organs and causes
systemic fungal infections in neutropenic individuals, such as AIDS
patients and those undergoing cancer chemotherapy or
immunomodulation therapy for organ transplantation. Polyenes and azoles
are used to treat systemic Candida infections, but the
adverse effects of polyenes and the emergence of
Candida strains resistant to azole compounds make the
treatment of patients with systemic mycosis difficult (1).
Chitin is one of the essential components of the fungal cell wall. As
in Saccharomyces cerevisiae, C. albicans harbors
three chitin synthases, which are encoded by distinct genes called
CaCHS1 (2), CaCHS2 (3), and
CaCHS3 (4, 5). According to the sequences and functional
analogies, CaChs1p, CaChs2p, and CaChs3p are considered to correspond
to S. cerevisiae Chs2p (ScChs2p), Chs1p (ScChs1p),
and Chs3p (ScChs3p), respectively (2-13). CaChs2p is the most abundant
protein among the three C. albicans chitin synthases (13),
but it is not essential for viability, hyphal growth, or virulence (12,
14). CaChs1p and CaChs3p are required for septum formation and for a
large part of the cell wall synthesis, respectively (11, 14). The
expression of CaCHS2 and CaCHS3 is up-regulated
during the morphogenetic transition from yeast to hyphae (3, 4, 13),
whereas the expression of CaCHS1 remains low in both the
yeast and hyphal forms (3). Although the cachs3 null
mutants retained the ability to develop hyphae in vitro (11,
14), a null mutation of CaCHS3 significantly attenuated the
virulence (11), suggesting that the cell wall chitin plays important
roles in pathogenicity. Whereas neither CaCHS2 nor
CaCHS3 is essential for viability, the fact that a null
mutation of CaCHS1 is impossible implies that
CaCHS1 is essential for the growth of C. albicans
(14).
To understand more about the physiological importance of C. albicans chitin synthase 1 and to also develop a valuable
antifungal drug, we identified a novel chitin synthase inhibitor that
is highly specific to CaChs1p. The inhibitor designated RO-09-3143 inhibited the septum formation and the growth of C. albicans cells. Further characterization of the compound, using
the null mutant strains of the chitin synthase genes, showed that the
inhibition of CaChs1p only arrested the cell growth, but the inhibition
of CaChs1p and Chs2p was lethal in C. albicans.
 |
MATERIALS AND METHODS |
Synthesis of RO-09-3143 Inhibitor--
RO-09-3143 was
synthesized from 8-amino-4H-benz[1,4]oxazin-3-one by
successive reductive N-alkylations with
6,6-dimethylhepta-2,4-diynal and then with formalin. One gram of
8-amino-4H-benz[1,4]oxazin-3-one (6.1 mmol) and 2.9 g
of 6,6-dimethylhepta-2,4-diynal (21.64 mmol) were stirred in 100 ml of
methanol/acetic acid (98% MeOH, 2% AcOH) containing 960 mg of
NaBH3CN (15.28 mmol) at room temperature for 15 h.
Thereafter, 1.73 ml of 37% formalin (21.34 mmol) and 960 mg of
NaBH3CN (15.28 mmol) were added to the reaction mixture, and the reaction was further stirred at room temperature for 3 h.
The reaction mixture was evaporated under reduced pressure, and the
materials were partitioned between CH2Cl2 and
water. The organic layer was washed with saturated NaCl solution, dried
over anhydrous sodium sulfate, filtered through a filter paper, and concentrated under reduced pressure. Purification of RO-09-3143 was
carried out by silica gel column chromatography. After the crude
residue was applied onto a silica column (150 g of SiO2, 4 × 24 cm), RO-09-3143 was eluted with 700 ml of
CH2Cl2/acetone (20:1), which yielded 1.25 g of RO-09-3143 (with an overall yield of 69%).
8-Amino-4H-benz[1,4]oxazin-3-one was synthesized according to the method of Newbery and Phillips (15).
Cloning and Expression of CaCHS1, CaCHS2 and ScCHS2--
The
chitin synthase activities of CaChs1p, CaChs2p, and ScChs2p were
determined by expressing them under the control of the GAL1
promoter in S. cerevisiae. The entire open reading
frames of CaCHS1 and CaCHS2 were amplified
by polymerase chain reaction with genomic DNA isolated from the
wild-type CAI4. The resulting DNA fragments were cloned at the
XbaI site located downstream of the GAL1 promoter
of YpLX (16), generating YpL-CaCHS1 and YpL-CaCHS2. The
cloning of ScCHS2 and the construction of YpL-ScCHS2 are
already described in a previous paper (16). YpL-CaCHS1, YpL-CaCHS2, and
YpL-ScCHS2 were then transformed into the haploid S. cerevisiae strain, RRA400-1U (MATa his3 leu2 trp1 ura3
chs1 ::URA3 chs3 ::HIS3), in which a 2.1-kilobase
NcoI-NcoI region of the chromosomal
ScCHS1 and a 1.1-kilobase BglII-BglII
region of the chromosomal ScCHS3 were replaced by
URA3 and HIS3, respectively (16). The
Leu+ transformants were isolated and cultured at 30 °C
in yeast nitrogen base (Difco) supplemented with glucose and the
necessary amino acids. CaChs1p, CaChs2p, and ScChs2p were expressed by
culturing the S. cerevisiae cells bearing YpL-CaCHS1,
YpL-CaCHS2, or YpL-ScCHS2 in medium containing galactose at 30 °C
for 12 h. DNA sequences of the cloned CaCHS1 and
CaCHS2 were confirmed as described elsewhere (17). Primers
used to amplify CaCHS1 were
5'-GCGGCGTCTAGAATGCACAACATTAACAATGG-3' and
5'-GCGGCGTCTAGACTAATTTAATGGATTGTG-3', and the primers used to amplify
CaCHS2 were 5'-GGTCTAGAATGAGTTATAACAATCCC-3' and
5'-TCTAGACTATTTAGTGGCATGTTCACTTGC-3'.
Determination of Susceptibilities of C. albicans and S. cerevisiae Cells to Compounds--
Susceptibilities of C. albicans cells to RO-09-3143 and other compounds were determined
as MIC501 values,
which were calculated from the A600
obtained after culturing 104 cells of the wild-type CAI4
(18) in 0.1 ml of YPD medium at 30 °C for 24 h in the
presence or absence of various concentrations of the indicated
compounds. The fungicidal effects of RO-09-3143 on C. albicans and S. cerevisiae cells were also examined by
counting the number of colonies derived from the viable cells.
Approximately 104 C. albicans cells from the
wild-type CAI4 (18), the cachs2 null mutant (14), and the
cachs3 null mutant (14) and the same number of S. cerevisiae cells from ECY36-3D (MATa leu2 trp1 ura3 chs1-23
chs3) (9, 10) and ECY36-3C (MATa leu2 trp1 ura3 chs1-23
chs2 ::LEU2) (9, 10) were cultured in 0.1 ml of YPD medium in the presence or absence of the indicated
concentrations of RO-09-3143 and nikkomycin Z. At the indicated times
after the addition of nikkomycin Z and RO-09-3143, 20 µl of the
diluted cultures were spread onto YPD medium agar plates. After
incubation at 30 °C for 2 days, the number of colonies appearing on
the plates, which represented the number of viable cells in the
cultures, was counted.
Assays of Chitin Synthases--
Total membranes were prepared
from S. cerevisiae RRA400-1U cells carrying YpL-CaCHS1,
YpL-CaCHS2, or YpL-ScCHS2 as described previously (16). To determine
the activities of ScChs1p and ScChs3p, membranes were also prepared
from S. cerevisiae RRA400 (MATa his3 leu2 trp1 ura3
chs3 ::HIS3) (19), which carries no functional ScCHS3, and from S. cerevisiae
ECY36-3C (9, 10), which lacks the functional ScCHS1 and
ScCHS2. Although S. cerevisiae RRA400 and
RRA400-1U carry the authentic ScCHS2 gene, the chitin synthase activities derived from the endogenous ScCHS2 were
very low and, therefore, negligible (16). Before the performance of the
assays, these chitin synthases with the exception of ScChs3p were
activated by incubating the total membranes with trypsin (TPCK-treated,
Type XIII, Sigma) at 30 °C for 15 min followed by the addition of
soybean trypsin inhibitor (SBTI, Sigma) at a concentration twice that
of the trypsin added to the membranes. Activation of the chitin
synthases by trypsin was optimized for each experiment. Chitin synthase
assays were performed according to the method of Sburlati and Cabib
(20) in a standard 100-µl reaction mixture containing 30 mM Tris-HCl, pH 7.5, 5 mM MgCl2, 32 mM N-acetylglucosamine (GlcNAc), 0.1 mM [3H]UDP-GlcNAc (specific activity, 44,400 dpm/nmol), and 100 µg of protein of the total membranes at 30 °C
for 60 min. Acid-insoluble radioactivity was then counted with a
scintillation counter.
Calcofluor staining of the C. albicans and S. cerevisiae
Cells--
Cells of the C. albicans wild-type CAI4 (18),
the C. albicans cachs2 /cachs3 double null
mutant (14), the S. cerevisiae ECY36-3D (9, 10), and
the S. cerevisiae ECY36-3C (9, 10) were cultured in YPD
medium in the presence or absence of the indicated concentrations of
RO-09-3143. Twenty-four hours after the addition of RO-09-3143, the
cells were harvested, washed with water, treated with 100 µg/ml
Calcofluor White (Sigma), and examined by fluorescent microscopy.
 |
RESULTS |
Inhibition of CaChs1p Activity and C. albicans Growth by
RO-09-3143--
Because a null mutation of CaCHS1 is
impossible (14), CaCHS1 may be required for the growth of
the C. albicans cells. As a result, a specific inhibitor for
CaChs1p can be developed as a novel antifungal drug. To identify
such inhibitors, we expressed CaChs1p in S. cerevisiae
RRA400-1U cells, which harbors neither ScCHS1 nor
ScCHS3, under the control of the S. cerevisiae
GAL1 promoter (16). As mentioned above, the endogenous ScChs2p
activities of the total membranes of RRA400-1U were negligible (16). By screening the chemical libraries with the total membranes of S. cerevisiae cells overexpressing CaChs1p, we identified RO-41-0986 as a novel chitin synthase inhibitor (Fig.
1A). RO-41-0986 inhibited CaChs1p more strongly than did nikkomycin Z; the Ki
values of RO-41-0986 and nikkomycin Z to CaChs1p were 0.63 µM and 2.7 µM, respectively. Although
RO-41-0986 structurally resembles terbinafine, which is a specific
inhibitor of fungal squalene epoxidase, RO-41-0986 did not inhibit
C. albicans squalene epoxidase even at the concentration of
100 µM.

View larger version (20K):
[in this window]
[in a new window]
|
Fig. 1.
Structures of RO-41-0986 and RO-09-3143.
A, chemical structures of RO-41-0986 and RO-09-3143 together
with their Ki values to CaChs1p. B,
structure-activity relationship (SAR) of RO-41-0986
derivatives. Structure-activity relationship was determined according
to the potency to inhibit CaChs1p activity. Moieties represented as
X-Y, X, Y, W, Z, R, and the other two in the side chain,
which are indicated by arrows, were replaced by the
indicated substituents, and the potency of each compound to inhibit
CaChs1p was examined. "A > B" in the
structure-activity relationship indicates that the compound with A
substituent at the indicated moieties inhibited CaChs1p more than the
compound with B. " A B " indicates that the compound bearing A
substituent at the indicated moieties displayed a potency similar to
that with B substituent.
|
|
Next RO-41-0986 was chemically modified to improve its potency as a
CaChs1p inhibitor. Among several hundred derivatives, RO-09-3143 was
found to be one of the strongest inhibitors of CaChs1p (Fig.
1A) (21). Interestingly, RO-09-3143 was rather specific for
CaChs1p; it inhibited CaChs1p with a Ki value of
0.55 nM. ScChs2p was much less susceptible to RO-09-3143; the Ki value of ScChs2p to RO-09-3143 was 1 µM, which is about 2000 times greater than that for
CaChs1p (Fig. 2). Neither CaChs2p nor
ScChs1p activity was affected by the compound at the concentration of
100 µM. Inhibition kinetics demonstrated that RO-09-3143
inhibited CaChs1p and ScChs2p in a manner that was non-competitive to the substrate, UDP-GlcNAc, whereas nikkomycin Z
displayed its feature as a competitive inhibitor to the substrate (Fig.
2). Although an enzyme assay for CaChs3p has not yet been established,
RO-09-3143 did not significantly inhibit ScChs3p, which is functionally
analogous to CaChs3p even at the concentration of 100 µM.

View larger version (13K):
[in this window]
[in a new window]
|
Fig. 2.
Kinetics of the C. albicans
CaChs1p inhibition by nikkomycin Z and RO-09-3143.
Inhibition kinetics of C. albicans Chs1p by nikkomycin Z
(A) and RO-09-3143 (B). Inhibition kinetics of
S. cerevisiae Chs2p by RO-09-3143 (C) was
determined by Dixon plot analysis after enzyme assays in the presence
of various concentrations of the substrate and inhibitors. UDP-GlcNAc
concentrations used for the inhibition by nikkomycin Z were 0.1 mM ( ), 0.25 mM ( ), 1 mM
( ), and the UDP-GlcNAc concentrations used for the inhibition by
RO-09-3143 were 0.1 mM ( ), 0.25 mM ( ),
and 0.5 mM (1 mM for ScChs2p) ( ).
Concentrations of nikkomycin Z used for the assays were 0, 2, and 20 µM for CaChs1p, and concentrations of RO-09-3143 were 0, 2.75, 5.5, and 11 nM for CaChs1p and 0 µM,
0.66 µM, and 1.33 µM for ScChs2p.
|
|
During the course of chemical modification of RO-41-0986 and
identification of RO-09-3143, we also clarified the structure-activity relationship of the compound with respect to its inhibition of CaChs1p.
The structure-activity relationship of RO-09-3143 was described as
follows: 1) the t-butylacetylene moiety of the side chain
was essential, 2) the replacement of the ene-yne side chain with a
diyne increased the potency, 3) various substituents (R) were
acceptable on the aromatic amino group, suggesting that the R
substituent would be exposed to solvent, 4) the
N-unsubstituted amide moiety of the quinolinone ring was
required to keep the potency, and 5) the introduction of an oxygen or
sulfur atom into the lactam ring at the 4-position sustained the
potency (Fig. 1B). Additional results of the
structure-activity relationship have been published separately
(21).
Inhibition of C. albicans Growth by RO-09-3143--
If
CaCHS1 is an essential gene, RO-09-3143 should also abrogate
the growth of the C. albicans cells. As expected, RO-09-3143 inhibited the growth of C. albicans cells with the
MIC50 value of 0.27 µM. Because
CaCHS1 has been shown to be involved in septum formation
(14), we also asked whether RO-09-3143 affects the septum formation.
The wild-type CAI4 cells were treated with a non-lethal dose of
RO-09-3143 and then stained with Calcofluor White. In the presence of
10 µM RO-09-3143, the cells still somehow continued to
divide and increase in size but failed to form septa. Mother and
daughter cells did not separate, and there was no or only faint
fluorescence at the boundaries of these cells (Fig. 3, B and C);
however, cell separation occurred normally in the absence of
RO-09-3143, and strong fluorescence was detected at every septum of the
dividing cells (Fig. 3A). Essentially the same effects by
RO-09-3143 were observed with the
cachs2 /cachs3 double null mutant.
Untreated, those cells clearly sustained the ability to create septa as
judged by the fluorescence from Calcofluor White, but RO-09-3143
abolished the fluorescence at their septa and caused a failure of
completion of cell separation (Fig. 3, D-F). All
of these results demonstrate that RO-09-3143 inhibited the CaChs1p
activity even at a cellular level and arrested the cell growth through
a blockage of the CaChs1p function, that is septum formation.

View larger version (20K):
[in this window]
[in a new window]
|
Fig. 3.
Effects of RO-09-3143 on the septum formation
in C. albicans. C. albicans cells of
the wild-type CAI4 (A-C) and those of the
cachs2 /cachs3 double null mutant
(D-F) were cultured for 24 h in the presence (B,
C, E, and F) or absence (A and D)
of 10 µM of RO-09-3143. Thereafter, the cells were
stained with Calcofluor White. Septa and bud necks, where chitin was
accumulated heavily thereby producing strong fluorescence, were
detected under a fluorescent microscope.
|
|
The fact that it was impossible to create the C. albicans
mutant lacking CaCHS1 and that ScChs2p, although less
susceptible than CaChs1p, was also affected by RO-09-3143 prompted us
to further explore the mode of action of RO-09-3143 with the S. cerevisiae mutants deficient in the chitin synthase genes. In the
cells of ECY36-3C that are defective in both ScCHS1 and
ScCHS2, the strong fluorescence of Calcofluor White was
detected at bud neck but not at septa (Fig.
4D). On the contrary, in the
cells of ECY36-3D lacking ScCHS1 and ScCHS3 there
was strong fluorescence at septa but not at bud neck (Fig.
4A), confirming that ScChs3p was responsible for chitin
synthesis at bud neck, whereas ScChs2p was required for septum
formation (10). The fluorescence at bud neck in the ECY36-3C cells
remained even in the presence of a non-lethal dose (200 µM) of RO-09-3143 (Fig. 4, E and
F), but the fluorescence from the septa of ECY36-3D cells
almost completely disappeared after the addition of 200 µM RO-09-3143 (Fig. 4, B and C).
Thus, it appears that in C. albicans and S. cerevisiae, RO-09-3143 specifically interferes with the chitin
synthesis that is dependent on the activities of CaChs1p and
ScChs2p.

View larger version (19K):
[in this window]
[in a new window]
|
Fig. 4.
Effects of RO-09-3143 on the septum formation
in S. cerevisiae. S. cerevisiae cells
of ECY36-3D (scchs1 /scchs3 mutant)
(A-C) and those of ECY36-3C
(scchs1 /scchs2 mutant)
(D-F) were cultured for 24 h in the
presence (B, C, E, and F) or absence
(A and D) of 200 µM RO-09-3143.
Thereafter, the cells were stained with Calcofluor White. Septa and bud
necks, where chitin was accumulated heavily thereby producing strong
fluorescence, were detected under a fluorescent microscope.
|
|
Although the above results indicate that CaCHS1 is essential
for the growth of C. albicans cells, it still remains
unclear as to whether inhibition of CaChs1p is lethal or not. Because the complete shut-off of the CaCHS1 expression has not yet
been established, we addressed this possibility by using RO-09-3143. As
shown in Fig. 5, RO-09-3143 only arrested
the growth of the wild-type CAI4 cells. The number of viable cells did
not change until 20 h in the presence of RO-09-3143; the cell
number gradually increased and reached a plateau by 80 h
demonstrating that the blockage of the CaChs1p function resulted in
cell growth arrest in C. albicans. Interestingly, however,
RO-09-3143 caused the death of the C. albicans cells in the
presence of nikkomycin Z, a substrate analog of chitin synthase (22,
23). In S. cerevisiae, nikkomycin Z preferably inhibits
ScChs1p and ScChs3p (24); the defects in both ScCHS2 and
ScCHS3 are lethal in S. cerevisiae (10).
Therefore, one explanation for the above result may be that the dual
inhibition of CaChs1p and CaChs3p is also lethal in C. albicans. We validated this possibility by examining the effects
of RO-09-3143 on the cachs2 and cachs3 null
mutants. Although there was a transient decrease in the number of
viable cells, RO-09-3143 did not kill the cachs3 null
mutant. The transient decrease in the number of the viable
cachs3 null mutant cells after the addition of
RO-09-3143, however, would be an artifact of the colony assay because
the cachs3 null mutant cells became highly aggregated and
sometimes tended to form hyphae, especially in the presence of
RO-09-3143 (data not shown). On the contrary, RO-09-3143 caused cell
death in the cachs2 null mutant; more than 99.9% of the
cachs2 null mutant cells were thought to be dead 6 h
after addition of RO-09-3143 (Fig. 5). Thus, it appears that inhibition
of CaChs1p can only arrest cell growth, but simultaneous inhibition of
CaChs1p and CaChs2p is lethal in C. albicans.

View larger version (13K):
[in this window]
[in a new window]
|
Fig. 5.
Effects of nikkomycin Z and RO-09-3143 on the
viability of C. albicans. C. albicans
cells of the wild-type CAI4, the cachs2 null mutant
(chs2( / )), and the cachs3 null mutant
(chs3( / )) were cultured in the presence or absence of 10 µM nikkomycin Z and 20 µM RO-09-3143. At
the indicated times, samples of the cultures were diluted and spread
onto agar plates. The number of viable cells in the culture was
determined by counting the number of colonies appearing on the agar
plates. , none; , nikkomycin Z; , RO-09-3143; , nikkomycin
Z and RO-09-3143.
|
|
As RO-09-3143 inhibited the ScChs2p activity and septum formation in
ECY36-3D (scchs1 /scchs3 mutant) cells, we
also examined the effects of the compounds on the viability of these
cells. The number of the viable ECY36-3D cells but not ECY36-3C
(scchs1 /scchs2 mutant) cells decreased by
about 90% at 24 h after the addition of 300 µM
RO-09-3143. As in the C. albicans cachs3 null mutant cells, the decrease in the number of viable ECY36-3D cells was transient; at 72 h there was no significant difference in the number of the viable cells between ECY36-3D and ECY36-3C cells (data
not shown). Further increase in the concentration of RO-09-3143, however, resulted in precipitation of the compound and did not cause
cell death of the ECY36-3D cells.
 |
DISCUSSION |
In this study, we identified RO-09-3143 as a highly potent and
specific inhibitor of C. albicans Chs1p. Although its effect on ScChs2p was remarkably weaker than its effect on CaChs1p, RO-09-3143 also inhibited the activity of S. cerevisiae Chs2p (a
functional homolog of CaChs1p) but not the activity of ScChs1p that is
a homolog of CaChs2p. This suggests that RO-09-3143 is interactive only
with chitin synthases that belong to the family of S. cerevisiae Chs2p. In vivo, RO-09-3143 abrogated septum
formation and arrested the growth of C. albicans cells. This
result of RO-09-3143 suggests that septum formation is an essential
process of cell division in C. albicans. In fact, RO-09-3143
reduced the fungal burden in kidneys and prolonged the survival of mice
that had been systemically infected with a lethal dose of C. albicans.2 Although the
deletion of ScCHS2, which is functionally equivalent to
CaCHS1 and thereby responsible for septum formation, is
viable in S. cerevisiae, it also delays the cell growth and
causes aberrant morphology in S. cerevisiae (8,
10).
On the other hand, RO-09-3143 caused cell death in the
cachs2 null mutant but not in the cachs3
null mutant in C. albicans. This was a rather unexpected
result because in S. cerevisiae a double disruption of
ScCHS1 and ScCHS2 is still viable, and only the
simultaneous inactivation of ScCHS2 and ScCHS3 is
lethal (10). Furthermore, the addition of RO-09-3143 and nikkomycin Z
to the wild-type C. albicans cells also led to cell death,
although neither compound was a fungicidal agent for C. albicans when used alone. By using the S. cerevisiae
chitin synthases, nikkomycin Z has been shown to be rather selective to
ScChs1p and ScChs3p. The Ki value of nikkomycin Z to
ScShs2p is 4000 times greater than the Ki value of
nikkomycin Z to ScChs1p and 700 times greater than the
Ki value of nikkomycin Z to ScChs3p (24). Also in
C. albicans, we observed that CaChs2p was highly susceptible
to nikkomycin Z. Although the enzyme assay for CaChs3p and the
susceptibilities of CaChs3p to nikkomycin Z remain to be established,
the above results strongly suggest that the lethality caused by the
addition of RO-09-3143 and nikkomycin Z is also a result of the dual
inhibition of CaChs1p and CaChs2p. In S. cerevisiae,
RO-09-3143 also transiently reduced the number of viable cells of
ECY36-3D (scchs1 /scchs3 mutant), but it
failed to kill these cells. The failure of RO-09-3143 to cause cell
death of ECY36-3D presumably may be because of the lower susceptibility of ScChs2p to RO-09-3143 and also to a limited water solubility of the compound.
Although RO-09-3143 transiently reduced the number of viable cells of
the C. albicans cachs3 null mutant, we considered that this would be the consequence of the highly clumpy feature of the
cachs3 null mutant cells, and thereby, an artifact of the colony assay. Another possibility may be that the stability of RO-09-3143 influenced the killing kinetics of C. albicans
cachs2 and cachs3 null mutants differently. In
fact, in an animal model the initial step of the major RO-09-3143
metabolism was N-demethylation, which drastically reduced
the potency as a CaChs1p inhibitor; the MIC50 value
of the demethylated form of RO-09-3143 was about 1000 times greater
than that of the intact RO-09-3143. However, this possibility is
unlikely because doubling times in the YPD medium of the
cachs2 and cachs3 null mutants were
similar, and the half-life of RO-09-3143 in the C. albicans
conditioned medium was longer than 5 h, which is sufficient to
cover several cell cycles of these mutant cells. In fact, further
addition of RO-09-3143 at 12 and 24 h after the first addition of
RO-09-3143 did not cause cell death, and it only delayed recovery of
the growth of the cachs3 null mutant cells.
Whereas the dual inhibition of CaChs1p and CaChs2p appears to be lethal
in C. albicans, the function of CaChs2p is still obscure despite the fact that its protein level is supposed to be much higher
than that of the other two chitin synthases (13). In S. cerevisiae, ScChs1p, the functional homolog of CaChs2p, is believed to repair the cell wall at the bud scar during and/or after
bud separation (7). We and others (12-14) also disrupted CaCHS2 in C. albicans and found that the
disruption of CaCHS2 slowed down the germ tube formation but
did not affect the morphology, cell growth in vitro, septum
formation, or virulence. Moreover, a decrease of the chitin contents in
the hyphae of the cachs2 null mutants depended on the
methods used to extract chitin from the cells (13). Nevertheless, the
results of this study imply that CaChs2p has some unknown function that
may in part be overcome by CaChs1p.
 |
ACKNOWLEDGEMENTS |
We thank E. Cabib for ECY36-3C and ECY36-3D,
W. Fonzi for CAI4, and S. B. Miwa and F. Ford for reading the manuscript.
 |
FOOTNOTES |
*
This work was supported in part by the Human Science Fund of
Japan. RO-09-3143 is not patented and is free for any research use.The costs of publication of this
article were defrayed in part by the
payment of page charges. The article
must therefore be hereby marked
"advertisement" in
accordance with 18 U.S.C. Section
1734 solely to indicate this fact.
¶
To whom correspondence should be addressed: Dept. of Oncology,
Nippon Roche Research Center, 200 Kajiwara, Kamakura, Kanagawa 247-8530, Japan. Tel.: 81-467-45-4382; Fax: 81-467-45-6782; E-mail: hisafumi.okabe@roche.com.
Published, JBC Papers in Press, August 4, 2000, DOI 10.1074/jbc.M003634200
2
M. Sudoh, T. Yamazaki, M. Arisawa, and H. Yamada-Okabe, manuscript in preparation.
 |
ABBREVIATIONS |
The abbreviation used is:
MIC50, minimum inhibitory concentration.
 |
REFERENCES |
| 1.
|
Georgiev, V. St.
(1998)
Infectious Disease in Immunocompromised Hosts
, pp. 739-1166, CRC Press, Boca Raton, FL
|
| 2.
|
Au-Young, J.,
and Robbins, P. W.
(1990)
Mol. Microbiol.
4,
197-207
|
| 3.
|
Chen-Wu, J. L.,
Zwicker, J.,
Bowen, A. R.,
and Robbins, P. W.
(1992)
Mol. Microbiol.
6,
497-502
|
| 4.
|
Sudoh, M.,
Nagahashi, S.,
Doi, M.,
Ohta, A.,
Takagi, M.,
and Arisawa, M.
(1993)
Mol. Gen. Genet.
241,
351-358
|
| 5.
|
Sudoh, M.,
Watanabe, M.,
Mio, T.,
Nagahashi, S.,
Yamada-Okabe, H.,
Takagi, M.,
and Arisawa, M.
(1995)
Microbiology
141,
2673-2679
|
| 6.
|
Bulawa, C. E.,
Slater, M.,
Cabib, E.,
Au-Young, J.,
Sburlati, A.,
Adair, W. L., Jr.,
and Robbins, P. W.
(1986)
Cell
46,
213-225
|
| 7.
|
Cabib, E.,
Sburlati, A.,
Bowers, B.,
and Silverman, S. J.
(1989)
J. Cell Biol.
108,
1655-1672
|
| 8.
|
Silverman, S. J.,
Sburlati, A.,
Slater, M. L.,
and Cabib, E.
(1988)
Proc. Natl. Acad. Sci. U. S. A.
85,
4735-4739
|
| 9.
|
Valdivieso, M. H.,
Mol, P. C.,
Shaw, J. A.,
Cabib, E.,
and Duran, A.
(1991)
J. Cell Biol.
114,
101-109
|
| 10.
|
Shaw, J. A.,
Mol, P. C.,
Bowers, B.,
Silverman, S. J.,
Valdivieso, M. H.,
Duran, A.,
and Cabib, E.
(1991)
J. Cell Biol.
114,
111-123
|
| 11.
|
Bulawa, C.,
Miller, D.,
Henry, L. K.,
and Becker, J.
(1995)
Proc. Natl. Acad. Sci. U. S. A.
92,
6216-6220
|
| 12.
|
Gow, N. A. R.,
Robbins, P. W.,
Lester, J. W.,
Brown, A. J.,
Fonzi, W. A.,
Chapman, T.,
and Kinsman, O. S.
(1994)
Proc. Natl. Acad. Sci. U. S. A.
91,
6216-6220
|
| 13.
|
Munro, C. A.,
Schofield, D. A.,
Gooday, G. W.,
and Gow, N. A. R.
(1998)
Microbiology
144,
391-401
|
| 14.
|
Mio, T.,
Yabe, T.,
Sudoh, M.,
Satoh, Y.,
Nakajima, T.,
Arisawa, M.,
and Yamada-Okabe, H.
(1996)
J. Bacteriol.
178,
2416-2419
|
| 15.
| Newbery, G., and Phillips, M. A. (1928) J. Chem.
Soc. (Lond.) 3046-3050
|
| 16.
|
Nagahashi, S.,
Sudoh, M.,
Ono, N.,
Sawada, R.,
Yamaguchi, E.,
Uchida, Y.,
Mio, T.,
Takagi, M.,
Arisawa, M.,
and Yamada-Okabe, H.
(1995)
J. Biol. Chem.
270,
13961-13967
|
| 17.
|
Sambrook, J.,
Fritsch, E. F.,
and Maniatis, T.
(1989)
Molecular Cloning: A Laboratory Manual
, 2nd Ed.
, pp. 18.60-18.75, Cold Spring Harbor Laboratories, Cold Spring Harbor, NY
|
| 18.
|
Fonzi, W. A.,
and Irwin, M. Y.
(1993)
Genetics
134,
717-728
|
| 19.
|
Motoyama, T.,
Sudoh, M.,
Horiuchi, H.,
Ohta, A.,
and Takagi, M.
(1994)
Biosci. Biotechnol. Biochem.
58,
1685-1693
|
| 20.
|
Sburlati, A.,
and Cabib, E.
(1986)
J. Biol. Chem.
261,
15147-15152
|
| 21.
|
Masubuchi, K.,
Taniguchi, M.,
Umeda, I.,
Hattori, K.,
Suda, H.,
Kohchi, Y.,
Isshiki, Y.,
Sakai, T.,
Kohchi, M.,
Shirai, M.,
Okabe, H.,
Sudoh, M.,
Yamazaki, T.,
and Shimma, N.
(2000)
Bioorg. Med. Chem. Lett.
10,
4374-4377
|
| 22.
|
Cabib, E.
(1991)
Antimicrob. Agents Chemother.
35,
170-173
|
| 23.
|
Duran, A.,
and Cabib, E.
(1978)
J. Biol. Chem.
253,
4419-4425
|
| 24.
|
Gaughran, J. P.,
Lai, M. H.,
Kirsch, D. R.,
and Silverman, S. J.
(1994)
J. Bacteriol.
176,
5857-5860
|
Copyright © 2000 by The American Society for Biochemistry and Molecular Biology, Inc.

CiteULike Complore Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
C. W. Moore, J. McKoy, R. Del Valle, D. Armstrong, E. M. Bernard, N. Katz, and R. E. Gordon
Fungal Cell Wall Septation and Cytokinesis Are Inhibited by Bleomycins
Antimicrob. Agents Chemother.,
October 1, 2003;
47(10):
3281 - 3289.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Ichinomiya, T. Motoyama, M. Fujiwara, M. Takagi, H. Horiuchi, and A. Ohta
Repression of chsB expression reveals the functional importance of class IV chitin synthase gene chsD in hyphal growth and conidiation of Aspergillus nidulans
Microbiology,
May 1, 2002;
148(5):
1335 - 1347.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E.-I. Hwang, B.-M. Kwon, S.-H. Lee, N.-R. Kim, T.-H. Kang, Y.-T. Kim, B.-K. Park, and S.-U. Kim
Obovatols, new chitin synthase 2 inhibitors of Saccharomyces cerevisiae from Magnolia obovata
J. Antimicrob. Chemother.,
January 1, 2002;
49(1):
95 - 101.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Nishikawa, J. B. Poster, Y. Jigami, and N. Dean
Molecular and Phenotypic Analysis of CaVRG4, Encoding an Essential Golgi Apparatus GDP-Mannose Transporter
J. Bacteriol.,
January 1, 2002;
184(1):
29 - 42.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 2000 by the American Society for Biochemistry and Molecular Biology.
|
Advertisement
Advertisement
|